(13-091) The Role of Sugammadex for Neuromuscular Blockade Reversal in Neuro Critical Care Patients

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: University of Tennessee Medical Center
Residency Program Type: PGY2 (Critical Care Pharmacy)
Residency Program Location: Tennessee

Co-Author(s): Gianna Antinone, Michael Behal, Leslie Hamilton, Mary Massaro

Primary Author(s)

Autumn B. McClung, PharmD

PGY2 Critical Care Pharmacy Resident
University of Tennessee Medical Center